<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>ejm</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Ege Tıp Dergisi</journal-title>
            </journal-title-group>
                            <issn pub-type="ppub">1016-9113</issn>
                                        <issn pub-type="epub">2147-6500</issn>
                                                                                            <publisher>
                    <publisher-name>Ege University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.19161/etd.1620976</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Haematology</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Hematoloji</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <article-title>The relationship between endothelial activation and stress index with survival and early mortality in acute myeloid leukemia</article-title>
                                                                                                                                                                                                <trans-title-group xml:lang="tr">
                                    <trans-title>Akut miyeloid lösemide endotel aktivasyonu ve stres indeksi ile sağkalım ve erken mortalitenin ilişkisi</trans-title>
                                </trans-title-group>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0001-6923-1470</contrib-id>
                                                                <name>
                                    <surname>Demirci</surname>
                                    <given-names>Ufuk</given-names>
                                </name>
                                                                    <aff>TRAKYA ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-7155-7610</contrib-id>
                                                                <name>
                                    <surname>Umit</surname>
                                    <given-names>Elif</given-names>
                                </name>
                                                                    <aff>TRAKYA ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-1474-9202</contrib-id>
                                                                <name>
                                    <surname>Aslan</surname>
                                    <given-names>Erge</given-names>
                                </name>
                                                                    <aff>TRAKYA ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-1361-6213</contrib-id>
                                                                <name>
                                    <surname>Alp Kırkızlar</surname>
                                    <given-names>Tuğcan</given-names>
                                </name>
                                                                    <aff>TRAKYA ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0001-7523-8599</contrib-id>
                                                                <name>
                                    <surname>Kırkızlar</surname>
                                    <given-names>Hakkı Onur</given-names>
                                </name>
                                                                    <aff>TRAKYA ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-2073-5405</contrib-id>
                                                                <name>
                                    <surname>Demir</surname>
                                    <given-names>Ahmet Muzaffer</given-names>
                                </name>
                                                                    <aff>TRAKYA ÜNİVERSİTESİ, TIP FAKÜLTESİ</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20251208">
                    <day>12</day>
                    <month>08</month>
                    <year>2025</year>
                </pub-date>
                                        <volume>64</volume>
                                        <issue>4</issue>
                                        <fpage>606</fpage>
                                        <lpage>611</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20250202">
                        <day>02</day>
                        <month>02</month>
                        <year>2025</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20250703">
                        <day>07</day>
                        <month>03</month>
                        <year>2025</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 1962, Ege Journal of Medicine</copyright-statement>
                    <copyright-year>1962</copyright-year>
                    <copyright-holder>Ege Journal of Medicine</copyright-holder>
                </permissions>
            
                                                                                                <abstract><p>Aim: The Endothelial Activation and Stress Index (EASIX) score is used as a marker of endothelial damage and used to predict acute graft-versus-host disease and sinusoidal obstruction syndrome. We wanted to evaluate the effects of EASIX, modified EASIX (mEASIX) and sepsis modified EASIX (sEASIX) on early mortality and overall survival (OS) in patients with acute myeloid leukemia.Materials and Methods: We reviewed patients diagnosed and followed up with Acute Myeloid Leukemia (AML) in our Hematology Department, retrospectively. Patients between 18 -70 years of age and who were administered 7+3 (7 days cytarabine, and 3 days anthracycline) chemotherapy protocol (except acute promyelocytic leukemia) were included. EASIX, mEASIX and sEASIX scores of the patients, both at the time of diagnosis and at the end of the 4th week, were calculated.Results: Seventy-five patients were included in the study. The mean age was 49.05 (19-68) years and 41% were alive. EASIX and mEASIX scores measured both at the time of diagnosis and at the end of induction therapy were found to be significantly associated with early mortality (p=0.01, p</p></abstract>
                                                                                                                                    <trans-abstract xml:lang="tr">
                            <p>Amaç: Endotelyal Aktivasyon ve Stres İndeksi (EASIX) skoru, endotel hasarının bir belirteci olarak ve akut greft-versus-host hastalığı ile sinüzoidal obstrüksiyon sendromunu öngörmek için kullanılır. Bu çalışmada, EASIX, modifiye EASIX (mEASIX) ve sepsis modifiye EASIX (sEASIX) skorlarının akut miyeloid lösemi hastalarında erken mortalite ve genel sağkalım (OS) üzerindeki etkilerini değerlendirmek amaçlanmıştır.Gereç ve Yöntem:  Gereç ve Yöntem: Hematoloji kliniğimizde Akut Miyeloid Lösemi (AML) tanısı konulan ve takibi yapılan hastaları retrospektif olarak inceledik. Çalışmaya 18-70 yaş aralığında, 7+3 (7 gün sitarabin ve 3 gün antrasiklin) kemoterapi protokolü uygulanan (akut promiyelositik lösemi hariç) hastalar dahil edildi. Hastaların tanı anında ve dördüncü haftanın sonundaki EASIX, mEASIX ve sEASIX skorları hesaplandı.Bulgular:  Çalışmaya 75 hasta dahil edildi. Ortalama yaş 49,05 (19-68) yıldı ve %41&#039;i hayattaydı. Hem tanı anında hem de indüksiyon tedavisinin sonunda ölçülen EASIX ve mEASIX skorlarının erken mortalite (p=0,01, p</p></trans-abstract>
                                                            
            
                                                            <kwd-group>
                                                    <kwd>Endothelial dysfunction</kwd>
                                                    <kwd>  Acute myeloid leukemia</kwd>
                                                    <kwd>  Early mortality</kwd>
                                            </kwd-group>
                                                        
                                                                            <kwd-group xml:lang="tr">
                                                    <kwd>Endothelial dysfunction</kwd>
                                                    <kwd>  acute myeloid leukaemia</kwd>
                                                    <kwd>  early mortality</kwd>
                                            </kwd-group>
                                                                                                            </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">Shallis RM, Wang R, Davidoff A and et al. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev. 2019 Jul;36:70-87.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Song GY, Jung SH, Kim K, et al. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma. BMC Cancer. 2020 Aug 24;20(1):803.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">Merz A, Germing U, Kobbe G, et al. EASIX for prediction of survival in lower-risk myelodysplastic syndromes. Blood Cancer J. 2019 Nov 11;9(11):85.</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Pennisi M, Sanchez-Escamilla M, Flynn JR, et al. Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Adv. 2021 Sep 14;5(17):3397-3406.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Li Y, Jiang L, Song T, et al. A call for better understanding the role of albumin in mediating VE-cadherin phosphorylation and endothelial barrier dysfunction in septic patients. Crit Care. 2021 Jul 1;25(1):232.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Sanchez-Escamilla M, Flynn J, Devlin S, et al. EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2023 May;58(5):498-505.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Vythoulkas D, Tsirigotis P, Griniezaki M, et aI. Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation. Cancers (Basel). 2023 Jan 22;15(3):680.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Aldecoa C, Llau JV, Nuvials X and Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020 Jun 22;10(1):85.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 Nov;86(5):1327-30.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
